Pachankis J, Chiaramonte D, Scheer J, Ankrum H, Eisenstadt B, Hobbs R
BMJ Open. 2025; 15(3):e086738.
PMID: 40032395
PMC: 11877267.
DOI: 10.1136/bmjopen-2024-086738.
Hahn A, Corcoran E, Danielson C
Contemp Clin Trials Commun. 2025; 44:101435.
PMID: 39944963
PMC: 11814518.
DOI: 10.1016/j.conctc.2025.101435.
Mostofsky E, Buring J, Come S, Tung N, Zhang C, Mukamal K
Breast Cancer Res. 2025; 27(1):5.
PMID: 39789640
PMC: 11720806.
DOI: 10.1186/s13058-024-01940-4.
Dember L, Hsu J, Mehrotra R, Cavanaugh K, Kalim S, Charytan D
JAMA Intern Med. 2025; 185(2):197-207.
PMID: 39786400
PMC: 11791705.
DOI: 10.1001/jamainternmed.2024.7140.
Pielage M, Rousian M, van Heteren S, Groenenberg I, Hillegers M, Steegers E
Prenat Diagn. 2024; 44(13):1603-1613.
PMID: 39439004
PMC: 11628214.
DOI: 10.1002/pd.6694.
Examining changes in pain interference via pandemic-induced isolation among patients receiving medication for opioid use disorder: a secondary data analysis.
Frohe T, Janssen T, Garner B, Becker S
BMC Public Health. 2024; 24(1):2581.
PMID: 39334184
PMC: 11428855.
DOI: 10.1186/s12889-024-20077-9.
A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.
Weng Y, Kruschwitz J, Rueda-Delgado L, Ruddy K, Boyle R, Franzen L
Elife. 2024; 13.
PMID: 39235858
PMC: 11377036.
DOI: 10.7554/eLife.97150.
Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial.
Helm A, Shaffer P, Gonzalez G, Li W, Olmstead T, Berlowitz D
Contemp Clin Trials. 2024; 145:107668.
PMID: 39163904
PMC: 11392628.
DOI: 10.1016/j.cct.2024.107668.
Fetal behavior and gestational serotonin reuptake inhibitor exposure: relationships between behavior, drug dosage, plasma drug level, and a measure of drug bioeffect.
Salisbury A, Anderson G, Yang A, Stika C, Rasmussen-Torvik L, Gollan J
Neuropsychopharmacology. 2024; 49(13):1968-1977.
PMID: 39127823
PMC: 11480508.
DOI: 10.1038/s41386-024-01923-1.
Greater ventral striatal functional connectivity in cigarette smokers relative to non-smokers across a spectrum of alcohol consumption.
Halcomb M, Dzemidzic M, Avena-Koenigsberger A, Hile K, Durazzo T, Yoder K
Brain Imaging Behav. 2024; 18(5):1121-1130.
PMID: 39106000
DOI: 10.1007/s11682-024-00903-9.
PT-IN-MIND: study protocol for a multisite randomised feasibility trial investigating physical therapy with integrated mindfulness (PT-IN-MIND) for patients with chronic musculoskeletal pain and long-term opioid treatment who attend outpatient....
Magel J, Beneciuk J, Siantz E, Fritz J, Garland E, Hanley A
BMJ Open. 2024; 14(7):e082611.
PMID: 39079926
PMC: 11293391.
DOI: 10.1136/bmjopen-2023-082611.
Reasons for choosing sober living houses and their associations with substance use recovery outcomes.
Mahoney E, Subbaraman M, Mericle A, Polcin D
Addict Behav Rep. 2024; 20:100557.
PMID: 39027409
PMC: 11252607.
DOI: 10.1016/j.abrep.2024.100557.
Relationship between alcohol intake based on daily smartphone-reported consumption and PEth concentrations in healthy volunteers.
Finanger T, Melby K, Spigset O, Andreassen T, Lydersen S, Skrastad R
Alcohol Alcohol. 2024; 59(4).
PMID: 38881524
PMC: 11180986.
DOI: 10.1093/alcalc/agae040.
Level and timing of product substitution in a trial of e-cigarettes for smokers not interested in quitting.
Sargent J, Pratt S, Brunette M, Ferron J, Santos M, Stoolmiller M
Tob Induc Dis. 2024; 22.
PMID: 38873183
PMC: 11170977.
DOI: 10.18332/tid/189220.
The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trial.
Jepsen P, Von Wowern N, Madsen L, Klausen M, During S, Benthien K
Pilot Feasibility Stud. 2024; 10(1):78.
PMID: 38755732
PMC: 11097510.
DOI: 10.1186/s40814-024-01504-5.
An mHealth Intervention for Gay and Bisexual Men's Mental, Behavioral, and Sexual Health in a High-Stigma, Low-Resource Context (Project Comunică): Protocol for a Randomized Controlled Trial.
Lelutiu-Weinberger C, Filimon M, Hoover D, Lixandru M, Hanu L, Dogaru B
JMIR Res Protoc. 2024; 13:e52853.
PMID: 38709550
PMC: 11106696.
DOI: 10.2196/52853.
Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse.
Fogelman N, Tate M, Wemm S, Sullivan L, Hart R, Vacey E
Addict Biol. 2024; 29(4).
PMID: 38619491
PMC: 11017971.
DOI: 10.1111/adb.13390.
A robust brain network for sustained attention from adolescence to adulthood that predicts later substance use.
Weng Y, Kruschwitz J, Rueda-Delgado L, Ruddy K, Boyle R, Franzen L
bioRxiv. 2024; .
PMID: 38617224
PMC: 11014614.
DOI: 10.1101/2024.04.03.587900.
Using causal mediation to examine self-efficacy as a mechanism through which continuing care interventions reduce alcohol use.
Brincks A, MacKinnon D, Gustafson D, McKay J
Psychol Addict Behav. 2024; 38(8):871-878.
PMID: 38546557
PMC: 11436481.
DOI: 10.1037/adb0001011.
Acceptability and feasibility of a mobile behavioral economic health intervention to reduce alcohol use in adults in rural areas.
Bayrakdarian N, Bonar E, Duguid I, Hellman L, Salino S, Wilkins C
Drug Alcohol Depend Rep. 2024; 11:100225.
PMID: 38545408
PMC: 10966148.
DOI: 10.1016/j.dadr.2024.100225.